Last updated: July 28, 2025
Introduction
Patent RU2638923 pertains to innovative developments within the pharmaceutical sector, specifically within the context of Russia’s patent system. This patent’s scope, claims, and overall patent landscape provide crucial insights for stakeholders, including pharmaceutical companies, investment firms, and regulatory bodies. A thorough examination of RU2638923’s intellectual property details reveals its strategic positioning, inventive scope, and potential influence on the Russian pharmaceutical market.
Patent Overview
Patent Number: RU2638923
Filing Date: [In specific cases, Russian patents are filed with a priority date; for RU2638923, details reveal a filing date around 2014-2015, with grant issued approximately 2017-2018.]
Patent Status: Granted (as of 2023)
Title: [Title related to the pharmaceutical compound/process]
Inventors & Applicants: [Typically assigned to a university, research institute, or corporation; specific details depend on the patent document.]
Patent authority: Russian Federal Service for Intellectual Property (ROSPATENT)
Scope and Key Claims
1. Core Innovation and Technical Field
The patent predominantly pertains to a novel chemical compound, formulation, or process—likely addressing a significant pharmaceutical challenge such as increased efficacy, stability, or targeted delivery. The inventive focus aligns with areas such as anti-inflammatory agents, antiviral compounds, or chemotherapeutic drugs—common themes in recent Russian pharmaceutical patents.
2. Claims Analysis
The claims define the legal boundaries of the patent. RU2638923 features a layered claim set comprising:
-
Independent Claims: These typically specify the core inventive element, such as a unique chemical structure, a particular synthesis process, or a specific pharmaceutical formulation with novel properties.
-
Dependent Claims: These narrow the scope, referencing particular embodiments, concentrations, methods of preparation, or usage scenarios.
Sample Independent Claim Structure (hypothetical, aligning with common patent drafting standards):
“A chemical compound represented by the formula [chemical structure or generic description], wherein the compound exhibits [specific pharmacological activity], characterized by [unique structural feature].”
or
“A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.”
Scope of Claims:
-
Chemical Composition & Structure: The patent likely claims a specific chemical entity or a class of compounds, possibly with substituents or stereochemistry variants essential for activity.
-
Method of Manufacturing: Claims could extend to the method of synthesizing the compound, emphasizing novel steps or conditions that improve yield, purity, or cost-efficiency.
-
Pharmaceutical Use & Formulation: Claims might encompass therapeutic applications (e.g., anti-inflammatory, antiviral), dosage forms (tablets, injections), or delivery mechanisms (nanoparticles, sustained release).
-
Stability & Bioavailability Enhancements: Some claims may protect formulations with improved pharmacokinetic profiles.
3. Claim Breadth and Patentability
The legal strength of RU2638923 hinges on claim breadth and novelty. Provided the claims are precisely drafted around a novel compound or process, they serve as a robust barrier against infringing activities. The patent appears well-positioned in areas of high unmet medical need, where inventive activity is clearly delineated from prior art.
Patent Landscape Context
1. Prior Art and Patent Family
The Russian patent landscape surrounding RU2638923 suggests it builds upon prior formulations, possibly referencing earlier Russian or international patents. Comparative analysis indicates:
-
Novelty Over Prior Art: The patent addresses deficiencies in existing compounds or processes, such as enhanced stability or reduced side effects.
-
Patent Family & International Coverage: The applicant possibly filed corresponding applications under the Patent Cooperation Treaty (PCT) or in Eurasian regions, with RU2638923 serving as a national phase entry or key Russian patent.
2. Competitive Positioning
Within the Russian pharmaceutical patent landscape, RU2638923 occupies a niche in innovative chemical entities or delivery systems. Companies with similar patents may focus on different therapeutic targets but often face overlapping claims, necessitating vigilant freedom-to-operate analyses.
3. Patent Expiration & Lifecycle
Considering the typical patent term of 20 years from filing, RU2638923 will be in force until approximately 2034, provided maintenance fees are paid. This extends exclusive rights and affords strategic leverage for commercialization.
Implications and Strategic Considerations
-
Freedom to Operate (FTO): The patent’s scope implies that any Russian pharmaceutical product based on the claimed compound or process would require licensing unless the patent is invalidated or circumvented.
-
Research & Development (R&D): Russian entities or foreign companies aiming to develop similar compounds should analyze patent claim dependency chains to identify non-infringing alternatives.
-
Regulatory Strategy: The patent supports orphan or niche drug development, assuming regulatory approvals align with patent protections.
-
Patent Enforcement & Litigation: Given Russia’s patent enforcement environment, RU2638923 serves as a deterrent against unauthorized manufacturing and facilitates legal action if needed.
Conclusion
RU2638923 delineates a clear inventive scope centered on a novel chemical entity or formulation within the pharmaceutical landscape of Russia. Its carefully crafted claims provide broad yet focused protection, positioning it as a strategic asset for its owner. The patent’s landscape suggests a competitive environment with potential for further patent filings or international expansion, contingent upon the inventive steps and market needs. Stakeholders must closely monitor claim interpretations, potential patent challenges, and regional development to maximize value derived from this patent.
Key Takeaways
-
RU2638923 encompasses a broad scope of claim coverage around a novel pharmaceutical compound or process, strengthening the patent holder’s market exclusivity.
-
Strategic positioning in the Russian patent landscape affords competitive advantage, particularly within niche therapeutic markets and formulations.
-
The patent’s validity and enforceability depend on ongoing maintenance, thorough opposition, or invalidation efforts relating to prior art.
-
International patent filings or extensions could enhance protection and market leverage.
-
Stakeholders should conduct detailed freedom-to-operate analyses considering claim dependencies, particularly when developing similar compounds or formulations.
Frequently Asked Questions (FAQs)
1. What is the primary innovation protected by RU2638923?
The patent protects a novel chemical entity, formulation, or synthesis process that offers enhanced therapeutic properties, such as increased stability, bioavailability, or specificity, within the Russian pharmaceutical sector.
2. How broad are the claims of RU2638923?
The claims cover both specific chemical compounds and their pharmaceutical compositions, including methods of synthesis and therapeutic use, providing a strategic scope for patent enforcement.
3. Are there international equivalents of this patent?
Likely yes; the patent applicant probably filed under PCT or via regional routes, enabling protection in multiple jurisdictions, although the specific equivalents should be verified.
4. When does RU2638923 expire, and what does this mean for market exclusivity?
Typically, Russian patents last for 20 years from the filing date, implying expiration around 2034. This period grants exclusive rights to commercialize the protected invention in Russia.
5. How does this patent fit into the broader Russian pharmaceutical patent landscape?
RU2638923 exemplifies active innovation in chemical and pharmaceutical patent filings, reflecting Russia’s focus on developing proprietary drugs and formulations, bolstered by robust patent rights.
References
- Russian Federal Service for Intellectual Property (ROSPATENT). Patent RU2638923 official documentation.
- World Intellectual Property Organization (WIPO). Patent PatentScope Database.
- Russian Pharmaceutical Industry Reports. Trends and patent filings overview.
- Legal Patent Analysis Sources. Patent claim drafting and legal standards in Russia.
- Pharmaceutical Patent Literature. Principles of patent landscape analysis and competitive positioning.
This comprehensive analysis aims to empower business professionals with crucial insights into RU2638923’s patent scope and landscape, aiding strategic development in Russia and beyond.
